ES2194904T3 - Agente carotenoide para inhibir la conversion de celulas epiteliales en tumores. - Google Patents

Agente carotenoide para inhibir la conversion de celulas epiteliales en tumores.

Info

Publication number
ES2194904T3
ES2194904T3 ES95914247T ES95914247T ES2194904T3 ES 2194904 T3 ES2194904 T3 ES 2194904T3 ES 95914247 T ES95914247 T ES 95914247T ES 95914247 T ES95914247 T ES 95914247T ES 2194904 T3 ES2194904 T3 ES 2194904T3
Authority
ES
Spain
Prior art keywords
tumors
conversion
inhibit
epithelial cells
carotenoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95914247T
Other languages
English (en)
Inventor
Lance Elliott Schlipalius
Julie A Buckmeier
Frank L Meyskens Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognis Australia Pty Ltd
Original Assignee
Cognis Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis Australia Pty Ltd filed Critical Cognis Australia Pty Ltd
Application granted granted Critical
Publication of ES2194904T3 publication Critical patent/ES2194904T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

AGENTE CAROTENOIDE QUE INHIBE LA CONVERSION DE CELULAS EPITELIALES EN TUMORES Y QUE INCLUYE UNA CANTIDAD EFECTIVA DEL COMPONENTE CAROTENOIDE INSOLUBLE AL AGUA EN UN MEDIO PORTADOR ADECUADO NO TOXICO.
ES95914247T 1994-04-08 1995-04-10 Agente carotenoide para inhibir la conversion de celulas epiteliales en tumores. Expired - Lifetime ES2194904T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM4931A AUPM493194A0 (en) 1994-04-08 1994-04-08 Therapeutic agent for inhibiting the conversion of epithelial cells to tumours

Publications (1)

Publication Number Publication Date
ES2194904T3 true ES2194904T3 (es) 2003-12-01

Family

ID=3779510

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95914247T Expired - Lifetime ES2194904T3 (es) 1994-04-08 1995-04-10 Agente carotenoide para inhibir la conversion de celulas epiteliales en tumores.

Country Status (8)

Country Link
EP (1) EP0754035B1 (es)
JP (1) JP3795075B2 (es)
AT (1) ATE234612T1 (es)
AU (1) AUPM493194A0 (es)
CA (1) CA2187367A1 (es)
DE (1) DE69529980T2 (es)
ES (1) ES2194904T3 (es)
WO (1) WO1995027483A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002513411A (ja) 1997-04-04 2002-05-08 ヘンケル コーポレーション 高いバイオアベイラビリティを有するルテインエステル
US6890961B2 (en) * 2002-02-01 2005-05-10 Micelle Products, Inc. Clear micellized formulations of β-carotene and method of treating leukoplakia
US6759436B2 (en) 2002-02-01 2004-07-06 Micelle Products, Inc. Clear micellized formulations of β-carotene and method of treating leukoplakia
US7351424B2 (en) 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509587A (en) * 1975-08-19 1978-05-04 Ajinomoto Kk Anti-tumour composition
US4680314A (en) * 1985-08-30 1987-07-14 Microbio Resources, Inc. Process for producing a naturally-derived carotene/oil composition by direct extraction from algae
JPH04502145A (ja) * 1988-06-24 1992-04-16 ウエスタン　ホールデイング　カンパニー　リミテツド テルペンのオゾニドおよびその医療的使用
FR2664164A1 (fr) * 1990-07-04 1992-01-10 Texinfine Patrinove Composition dermatologique ou cosmetique.
JPH04120019A (ja) * 1990-09-08 1992-04-21 Takao Matsuno 抗腫瘍剤
JPH05124958A (ja) * 1991-09-19 1993-05-21 Yukio Date 過酸化脂質低下作用を有する組成物
US5286474A (en) * 1992-10-22 1994-02-15 Arizona Board Of Regents, A Body Corporate, Acting For And On Behalf The Arizona State University Use of carotenoporphyrins as tumor localizing agents for diagnosis
EP0689427B1 (en) * 1993-03-22 2002-06-12 Cognis Australia Pty Ltd Water dispersible therapeutic carotenoid compounds
DE69424537T2 (de) * 1993-03-22 2001-11-15 Cognis Australien Pty.Ltd., Victoria Therapeutischer wirkstoff zur behandlung von melanomen

Also Published As

Publication number Publication date
ATE234612T1 (de) 2003-04-15
EP0754035B1 (en) 2003-03-19
EP0754035A1 (en) 1997-01-22
WO1995027483A1 (en) 1995-10-19
DE69529980D1 (de) 2003-04-24
JP3795075B2 (ja) 2006-07-12
JPH09511508A (ja) 1997-11-18
EP0754035A4 (en) 1998-07-08
CA2187367A1 (en) 1995-10-19
AUPM493194A0 (en) 1994-05-05
DE69529980T2 (de) 2004-02-19

Similar Documents

Publication Publication Date Title
ES2104673T3 (es) Hidroximetil(metilenciclopentil)purinas y pirimidinas.
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
AR015379A1 (es) Ascorbil-fosforil-colesterol
ES2196160T3 (es) Uso de una combinacion de tensioactivos, agentes quelantes y aceites esenciales para desinfeccion efectiva.
IL143901A0 (en) Use of cyclooxygenase-2- inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
CR5749A (es) Compuestos con cianoacrilato,curables por radiacion
ES2139877T3 (es) Agente anti-incrustacion.
ES2060983T3 (es) Utilizacion en cosmetica de una dispersion acuosa a base de organopolisilosanos y un copolimero de acrilato de amonio/acrilamida reticulados.
BR9713866A (pt) Composição farmacéutica
ATE285681T1 (de) Ein topisches nicht-zytotoxisches antimikrobielles hydrogel mit thixotropischen eigenschaften
ES2156840T1 (es) Medicamento que contiene polisulfato de pentosano e implante para tratar la fibrosis.
ES2065984T3 (es) Composicion detergente que contiene un perfume.
ES2179880T3 (es) Tratamiento del cancer utilizando un mutante del hsv.
ES2168285T3 (es) Agentes endoparasiticidas que contienen praziquantel y epsiprantel.
MX9300550A (es) Estructura de fibra absorbente.
CO5001019A1 (es) Composicion emulsionable para la represion de insectos, que se deriva del tipo de fenilpirazoles sustituidos en posi- cion 1, y no favorecen la formacion de cristales
CO4700420A1 (es) Formulacion transdermica
ES2160796T3 (es) Moleculas quimericas ribozima-arnsn que tienen actividad catalitica para arns nucleares.
ES2196813T3 (es) Vitamina e y esteres de la misma, para su uso en el tratamiento topico de patologias de la mucosa.
ES2156375T3 (es) Composicion de champu acondicionador.
ES2191417T3 (es) Composicion desinfectante.
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
ES2151517T3 (es) Efectos de filamentos de actina sobre la estructura y lisis de coagulos de fibrina.
ES2081978T3 (es) Un virus de polihedrosis nuclear con incorporacion multiple de la oruga del apio con actividad contra los lepidopteros.
ES2194904T3 (es) Agente carotenoide para inhibir la conversion de celulas epiteliales en tumores.